Nigeria plans to issue eurobonds and Islamic sukuk bonds to help finance its 2025 budget, according to Finance Minister Wale Edun. The debt will comprise a $1.7 billion eurobond and $500 million ...

Ventus Therapeutics announced the successful completion of the phase 1 clinical trial for VENT-03 with plans to initiate a phase 2 study for people with systemic lupus erythematosus (SLE) in 2025. The ...

Etihad Airways plans to spend up to $1 billion on new cabins, its CEO said, as reported Thursday by two media outlets. The Abu Dhabi-based airline is set to start by upgrading its Boeing 787 and ...

“The interim data from the SEAPORT 1 trial demonstrate that INZ-701 significantly raised PPi levels in patients with end-stage kidney disease and was well-tolerated in this high-risk population ...

The Manhattan trial of subway vigilante Daniel Penny opened Friday in the manslaughter case against the now 26-year-old, who put Jordan Neely in a deadly chokehold after the homeless man made ...

Forward-looking statements in this press release include, but are not limited to, statements regarding the design, objectives, timing, progress and results of the Phase 1 MYTHIC clinical trial of ...

today announced that the first patient has been dosed in the first-in-human Phase 1 trial (NCT06523803) to evaluate the safety and tolerability of the investigational therapy ZW171 in the ...

Global Phase 1 clinical trial will ... research and clinical development plans and timelines and results of operations, including impact on its clinical trial sites, collaborators, and contractors ...

Prelude Therapeutics (PRLD) announced the presentation of additional data from its ongoing Phase 1 open-label, dose-escalation trial of PRT3789, a first-in-class, highly selective SMARCA2 degrader ...

MHS Genesis needs about three years to move to the cloud before a sustainment contract for the Defense Department's massive health record system can be put out for bid, officials said. The ...

“We are very pleased with the positive outcome of our Phase 1 trial of MZE829, demonstrating its tolerability and establishing the dosing regimen that we plan to take into our Phase 2 trial in p ...

Professionals, take note. Visio Professional 2024 is the latest version of the popular software. It offers a comprehensive ...